Supplementary Figures S1 and S2: Association of MRD with Survival Outcomes in Myeloma Patients from the Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Kenneth C. Anderson,Daniel Auclair, Gary J. Kelloff,Caroline C. Sigman,Hervé Avet-Loiseau,Ann T. Farrell,Nicole J. Gormley,Shaji K. Kumar,Ola Landgren,Nikhil C. Munshi,Michele Cavo,Faith E. Davies,Alessandra Di Bacco,Jennifer S. Dickey, Steven I. Gutman, Howard R. Higley,Mohamad A. Hussein,J. Milburn Jessup,Ilan R. Kirsch, Richard F. Little,Robert D. Loberg, Jens G. Lohr,Lata Mukundan,James L. Omel,Trevor J. Pugh, Gregory H. Reaman,Michael D. Robbins, A. Kate Sasser, Nancy Valente,Elena Zamagni

crossref（2023）

引用 0|浏览0

暂无评分

摘要

1) Munshi Figures, 2) MRD Negativity Associated With Longer Progression-free Survival And Overall Survival In Newly Diagnosed Multiple Myeloma Patients

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要